Worldwide, breast cancer remains one of the prevalent healthcare concerns, where 50% of women don’t survive the disease due to late detection of the disease. That’s why early detection is critical and crucial, but often traditional methods face challenges that cause difficulty in detecting cancer in the early stage. But now it’s time to shift the focus from traditional techniques of screening to innovative technologies that promise great accuracy and early detection of breast cancer. The AI in breast cancer screening and thermal imaging for breast cancer detection are two groundbreaking solutions in the healthcare field. From urban hospitals to rural clinics and corporations, this innovative integration of AI with thermal imaging can revolutionize the early detection, curing and saving the life of cancer-exposed women.

This blog explores how innovative technology like NIRAMAI Thermalytix is transforming breast cancer detection, combining accuracy and care, to fight one of the most common diseases in women.

How does AI and Thermal Imaging Improve Early Breast Cancer Detection?

AI in Breast Cancer Screening

Artificial intelligence has re-envisioned healthcare by automating complex procedures and improving diagnostic accuracy. The AI breast cancer detection analyzes and identifies the abnormalities with speed and precision, even those abnormalities that are subtle to the traditional methods.

It is said that the use of AI has led to a significant reduction in false-positive rates by 37.3% and biopsy requests by 27.8% while maintaining sensitivity.

The role of AI in revolutionizing breast cancer screening  has become a significant mark in healthcare. AI is using the most recent and the largest datasets to better analyze the disease, which makes it an indispensable tool in the healthcare field. These tools prevent human errors, cut the diagnosis time and provide the right information, which, in turn, gives the opportunity for an earlier treatment.

Thermal Imaging Technology

Thermal imaging is a non-invasive breast cancer screening method which is paired with computer algorithms for thermal analysis. This may lessen subjectivity and enable automated quantitative interpretation, making the interpretation process more factual. Machine learning algorithms are used to provide scores based on medically interpretable criteria that characterize the metabolic activity within breast tissue and suggest the possibility of cancer. By identifying these abnormalities, thermal imaging will help in the early detection of breast cancers quickly and accurately. 

When combined with AI, thermal imaging technology achieves higher accuracy rates. AI-powered analysis of thermal data can identify patterns indicative of malignancies, enabling healthcare providers to act quickly and confidently.

Key Benefits of AI and Thermal Imaging in Breast Cancer Screening

Early Detection of Breast Cancer

Thermalytix, an AI-based breast cancer detection tool has been deployed across diverse clinical sites and screening camps, Its high precision ensures that women at higher risk are prioritized for early diagnosis and intervention. By enabling non-invasive cancer screening, AI-powered technologies like Thermalytix can identify cancer in its very early stages, significantly improving patient outcomes. Early detection allows for less aggressive treatment options and greatly increases the chances of full recovery.

Non-Invasive Screening Method

Thermal breast imaging offers a no-contact testing, painless and radiation-free method when compared to traditional methods. Which keeps the patient comfortable, and this way more women patients will be encouraged to have routine checkups and leave behind the fear factors of traditional methods.

Cost-Effective Solution

AI-based systems with thermal imaging provide for a significant reduction in breast cancer screening costs along with the avoidance of expensive infrastructure.

Portability and Accessibility

Thermal imaging-based diagnostic tools are portable and need minimal training in order to operate, which signifies that they are perfect for health clinics, community hospitals, and wellness centers of companies. Such devices are set in localities far from hospitals, making them available to the populations that do not have such services.

Scalability for Healthcare Providers

Hospitals and diagnostic centers can efficiently expand their screening services through AI-powered solutions, which enables them to serve more patients. 

Implications for Businesses and Healthcare Providers

Hospitals and Diagnostic Centers

Deployed across 150+ clinical sites and over 10000+ screening camps, Thermalytix’s AI algorithms have successfully triaged over 250,000 women from various socio economic backgrounds, demonstrating its scalability and reliability in diverse settings. Embracing this advanced AI-based technology alongside thermal imaging is crucial for healthcare providers, as it enhances diagnostic accuracy, streamlines processes by reducing waiting times, and enables more efficient breast cancer screening services. Hospitals and diagnostic centers leveraging these tools can significantly improve patient outcomes, making early detection and treatment more accessible and effective.

What is NIRAMAI?

ThermalytixTM, an artificial intelligence-powered computer-aided diagnostic engine, is the foundation of NIRAMAI’s solution. The solution analyzes thermal pictures using a cloud-hosted analytics program and high-resolution thermal sensing hardware.

Why NIRAMAI?

There have been many clinical studies published on NIRAMAI’S technology, which support its accuracy and reliability in detecting breast cancer in its early stages. Thermalytix is an artificial intelligence and machine learning-based tool that analyzes a person’s body’s thermogram, or heat map, to identify cancer early on. Thermalytix’s machine learning system was developed using a sizable thermogram dataset. Thermalytix™ demonstrated an overall sensitivity of 91.02% (95% CI, 81.8% to 96%), a specificity of 82.39% (95% CI, 78.2% to 86%), and an NPV of 97.88% in the detection of breast malignancy. The sensitivity and specificity in the asymptomatic screening population were 100% and 92.41%, respectively.

Conclusion

The convergence of AI and thermal imaging is transforming breast cancer screening, offering unprecedented accuracy, accessibility, and affordability. By adopting these advancements, we can collectively work towards reducing the global burden of breast cancer and saving countless lives.

For those seeking cutting-edge breast cancer screening solutions, NIRAMAI offers a pioneering approach. With its AI-powered, non-invasive, and portable device, Thermalytix empowers healthcare providers and corporations to make breast cancer screening accessible and reliable, ensuring early detection and better care outcomes.

Knowing your own breast health will help you to identify the early signs of breast cancer. Breast cancer affects millions of women every year, and some of them can be successfully treated and recovered by early detection. One needs to understand one’s own body and notice small changes that could signal a health issue, which is a pivotal step. We’ll bring you through the fundamentals of breast self-examination in this guide, giving you the skills to take control of your health. Let’s explore how getting to know your breasts can be one of the most proactive steps you can take on your wellness path.

Symptoms of Breast Cancer

It’s crucial to learn about breast cancer symptoms to receive the appropriate medical care as soon as possible. A lump or stiff spot in the breast or underarm, changes in the breast’s size or shape, and changes in the texture of the skin, such as redness or dimpling, are the usual symptoms. Constant Breast pain, that is constant, swelling that has no explanation, or noticeable veins on the breast might be other signs. Look out for nipple changes like scaling, discharge, and inversion which if bloody or without pressure, are the most concerning. Some symptoms may be painless or almost invisible, which is exactly why regular self-examinations and screenings are crucial. Do not hesitate to see a doctor if you notice anything unusual. Early symptom detection means quicker diagnosis and consequently better treatment options.

Breast Self-Examination

The survival rates and effective treatment options a patient can avail of, depend on the diagnosis of cancer at an early stage. A breast self-exam, which is a simple yet very vital procedure that you can perform on your own to monitor your health, is among the things you can do as part of breast cancer screening. Remember that self-awareness and breast self-examination are not a replacement for other breast cancer screening techniques. Because small breast tumors may not be detectable by breast self-examination.

However, what precisely are you supposed to be searching for? How should a self-examination be conducted? Learn about identifying early signs of breast cancer in this blog.

Step-by-step Guide to Self-Exam

These are the 4 steps of breast self-exam. 

Step 1: The first step is to place yourself directly in front of a mirror and do a visual inspection of your breasts. Check whether there are changes in the contour or size of the breast.

Step 2: Then, in the standing position, you should examine each breast using the pads of your fingers. Keep the fingertips flat, and make small circles with your fingers over quite a large area. Start checking from the upper breast, collarbone and then at the side resting on the breast.

Step 3: Then, a person should lie down on the back with one arm behind the head. This is called the supine position, and it is useful in the procedure as it aids in the even distribution of tissue. Once again, move in small circles over all surfaces of the breast using the hands.

In addition to this, review around the nipple for any discharge and the area around the nipple to alert to any changes in skin appearance. This breast exam which is popularly known as Video Stokes breast check can be performed regularly and should be a normal practice as it is important to the health of the breasts.

Step 4: Now, go to the floor, and lie down on your back. This allows the breast tissue to lie flat on the chest wall which facilitates the palpation process. Using one hand, the breast on that side should be examined using three fingers placed together and moving in circles around the entire area of the breast.

After doing one round of examination on one side, switch over and do the same on the other side. Switch between the two methods so that you make sure both of them are done frequently enough for you to notice the usual look and feel of your breasts.

How Often You Should Do A Self Breast Exam?

To keep the breasts in an optimal state, self-breast exams should be performed quite frequently. The recommended frequency is once a month. The doctors advise undertaking the exam around the same time during the cycle each month. This uniformity allows for easier identification of possible changes.

For menstruating women, it is best to select the first week after the periods when the breast tenderness and swelling are at a minimum. On the other hand, any day of the month is perfectly acceptable for women who have already attained the postmenopausal state.

Making this practice a norm in your life enables you to understand how your breast usually looks and feels, which is very helpful in identifying possible breast cancer at the early stages.

Self-examinations can indicate changes, so make a report of these changes to your doctor. 

Conclusion: 

Breast cancer needs to be detected early and one of the most effective actions you can take about your breast health is to perform regular self-exams. When you know how your breasts normally look and feel, it becomes easier to notice any changes that might indicate possible health problems. Innovations like NIRAMAI’s Thermalytix and self-awareness, when combined, are revolutionizing the early detection of breast cancer. NIRAMAI also provides an AI-based thermal imaging-powered, radiation-free, and economical screening that leads to timely diagnosis in underserved and rural areas.

By regularly performing self-exams, and visiting healthcare professionals as soon as something appears to be wrong, and using innovations like NIRAMAI Thermalytix, one can really enhance the chances of discovering breast cancer at an early stage and getting treated. Knowledge is power and you are in control of your health: early action does make a difference.

What is Breast Cancer and its Symptoms ?

Cancer is a disease characterized by the uncontrolled growth of body cells.  Breast cancer is the most common cancer in women worldwide. According to the World Health Organization, breast cancer is the second leading cause of cancer death in women, after lung cancer. Risk factors for developing breast cancer include obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, radiation, early age at first period, having children late in life or not at all, older age, and family history. Everywhere in the world, after puberty, women increase their risk of developing breast cancer as they age. Globally, breast cancer now represents one in four of all cancers in women [1]. Link

Symptoms of breast cancer include a lump in the breast, a change in the size or shape of the breast, nipple discharge, or a change in the appearance of the skin of the breast.

                  Source:– Facebook WHO page  

Figure 1: Symptoms of Breast Cancer

What is Breast Cancer Screening?

Breast cancer screening means checking a woman’s breasts for cancer before there are signs or symptoms of the disease in apparently healthy individuals. Early breast cancer detection can help find breast cancer at an early stage, And it is most likely to be treated successfully.

Breast Cancer Screening tests:   There are a variety of breast cancer screening tests available. The most common breast cancer screening tests are mammography, magnetic resonance imaging (MRI), breast ultrasound, breast thermography, and breast examination.

Screening is different from diagnosis in a few key ways. First, screening is typically done on asymptomatic individuals, while diagnosis is done on those who are already experiencing symptoms. Second, screening is typically done to identify potential cases of disease, while diagnosis is done to confirm the presence of disease. Finally, screening tests are typically less invasive and more affordable than diagnostic tests.

There are several ways to diagnose breast cancer. Your doctor may recommend a combination of diagnostic tests, including a physical exam.

The following techniques can diagnose breast cancer: 

NIRAMAI Approach

NIRAMAI has created an innovative software-based medical device that can help in early stage detection of breast cancer than in self-examination or conventional procedures. Our technology provides a portable, fully automated, low-cost, cancer screening solution that may be used in any facility, such as clinics, PHCs, etc.  Our technology is based on AI-powered breast cancer screening, Which uses unique machine learning algorithms to detect breast cancer accurately. This novel approach has several potential applications, including screening in large populations, routine preventive care, and hospital-based cancer diagnosis.

What is NIRAMAI?

NIRAMAI stands for “Non-Invasive Risk Assessment with Machine Intelligence.”

The core of NIRAMAI’s solution is Thermalytix™, a computer-aided diagnostic engine that is powered by artificial intelligence. The solution uses a high-resolution thermal sensing device and a cloud-hosted analytics solution for Thermal Breast Screening for cancer detection.

Thermalytix™ is a novel thermal imaging technology that has shown great promise in the early stage breast cancer detection. This technology uses infrared imaging to detect early signs of cancer, making it a potentially invaluable tool in breast cancer screening. The system consists of a camera that captures thermal images of the breast, a computer that processes the images, and software that interprets the results as shown in Figure 2, for the scan, the patient is asked to stand about 3 feet in front of the camera with her arms raised over her head while views of the breast are taken as shown in Figure 3.

Why NIRAMAI?

One of the benefits of Thermalytix™ has been more accuracy than traditional techniques in detecting early-stage breast cancer, and it also has the potential to be used in conjunction with other breast cancer screening modalities such as mammograms and Ultrasound. Thermalytix™ is a machine learning and AI breast cancer screening that uses the thermogram (heat map) of a person’s body to detect early signs of cancer. The machine learning algorithm of Thermalytix™ trained on a large dataset of thermograms. Thermalytix™ demonstrated an overall sensitivity of 91.02% (95% CI, 81.8% to 96%), a specificity of 82.39% (95% CI, 78.2% to 86%) and an NPV of 97.88% in the detection of breast malignancy. The sensitivity and specificity in the asymptomatic screening population were 100% and 92.41%, respectively. [2]  link

Figure 2: Thermalytix and its accessories                                Figure 3: The screening setup

NIRAMAI’s Thermalytix has tremendously impacted society by providing non-invasive breast cancer screenings to rural women and partnering with corporations to provide screenings to their employees. NIRAMAI has also been featured in the media, which has helped to raise awareness about breast cancer and the importance of early detection. Explore to know more at Niramai’s home page and Facebook page . 

 Integrating Thermalytix in the clinical care pathway

Breast cancer management guidelines 2019

Here you may find that NIRAMAI’s published clinical studies of breast cancer support that the company’s technology is accurate and reliable in detecting breast cancer. These studies also indicate that NIRAMAI’s technology may be more effective in detecting early-stage breast cancer, which is often more treatable.

Title	Aim	Study Designs	Journals
Observational Study to Evaluate the Clinical Efficacy of Thermalytix for Detecting Breast Cancer in Symptomatic and Asymptomatic Women (2020)	To test Thermalytix, an AI-based computer-aided diagnostics (CADx) engine, to identify breast cancer by comparing CADx data with routine screening techniques.	Observational Study of 470 patients	American Society of Clinical Oncology Link
Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities in subjects who show possible symptoms of suspected breast cancer (2021)	Evaluation of Thermalytix’s performance in comparison to other standard breast cancer screening methods including mammogram/ ultrasound.	Prospective multicentre study of 258 patients	British Medical Journal (BMJ) OpenLink
Performance of artificial intelligence-based breast cancer screening in a community setting: a real-world evaluation study (2022)	To review the Thermalytix test’s efficiency in identifying women at risk of breast cancer in community settings.	Observational Study of 13932 subjects	The Lancet OncologyLink
A Systematic Study to Evaluate the Benefit of using a Visualization Tool for Breast Thermography (2021)	To examine the sensitivity and specificity of the assessment of thermal images both with and without the usage of the software.	Systematic retrospective study of 326 patients	Thermology InternationalLink

Let’s promote early detection and prevention of this disease with NIRAMAI breast cancer screening. We believe that this test could potentially save many lives if more people are made aware of it. If you know anyone who may be at risk for breast cancer, please urge them to get screened. We hope with this artificial intelligence in healthcare we can fight breast cancer, As arly detection is key to surviving this disease. 

References:- 

[1] “Breast Cancer Statistics And Resources | Breast Cancer Research Foundation | BCRF,” Breast Cancer Research Foundation, Aug. 31, 2021. https://www.bcrf.org/breast-cancer-statistics-and-resources (accessed Oct. 17, 2022).

[2] S. T. Kakileti, H. J. Madhu, L. Krishnan, G. Manjunath, S. Sampangi, and H. v. Ramprakash, “Observational Study to Evaluate the Clinical Efficacy of Thermalytix for Detecting Breast Cancer in Symptomatic and Asymptomatic Women,” JCO Glob. Oncol., no. 6, pp. 1472–1480, Nov. 2020, doi: 10.1200/GO.20.00168.

1 in 8 women are expected to be diagnosed with breast cancer in their lifetime. This disease touches countless lives whether personally or through loved ones. Early detection of breast cancer can save lives so awareness and education on breast cancer are crucial as millions of  women are affected every year. Understanding the disease, its symptoms and methods of treatment can help women to take proactive steps. In this guide, we will discuss breast cancer, its causes, symptoms, and treatments. Whether you are looking for information for yourself or your loved ones, this will be beneficial for you.

What is Breast Cancer?

Breast cancer is a type of cancer that develops in the breast tissue. It occurs when cells begin to grow uncontrolled, thus forming tumors. 

Causes

Tumor formation results from genetic alterations that interfere with the regular cycle of cell division and death.

These gene alterations can be caused by various reasons. Some are hereditary, which means that certain gene mutations might run in their families and are thus inherited.These include the genes BRCA1 and BRCA2, which raise the risk of breast cancer significantly.

There are environmental factors as well. Hormones, some drugs, and radiation exposure can increase susceptibility. Overall, risk can also be influenced by lifestyle decisions like obesity alcohol use, and physical activity.

Early efforts to diagnose breast cancer depend on an understanding of these causes. We are better able to prevent this condition the more we understand what causes it.

Types of Breast Cancer

Breast cancer is a complex illness with multiple types, each with distinct traits.

Ductal Carcinoma: Breast cancer’s first stage is known as ductal carcinoma in situ (DCIS). In this case, aberrant cells are present inside the ducts but have not spread to the surrounding tissue. Invasive ductal carcinoma is more prevalent and more dangerous. Early breast Cancer detection is essential for improved outcomes because this type starts in the milk ducts and spreads to surrounding tissues.

Invasive Lobular Carcinoma: On the other hand, invasive lobular carcinoma starts in the lobules that generate milk. It frequently manifests differently than invasive ductal carcinoma which can occasionally cause delayed discovery.

There are also less prevalent types, such as triple-negative and inflammatory breast cancer. To guarantee that patients receive the right care for their particular disease, each subtype demands tailored approaches.

Symptoms 

The symptoms of breast cancer might differ from person to person. Early detection depends on being aware of these symptoms.

Alterations in how your breast tissue feels are one important typical sign. When people think of breast cancer symptoms, they often think of lumps. These could feel like enlarged spots or firm masses within the breast. It’s critical to observe any new growths that weren’t previously there.

Another sign to look out for is breast discharge. Attention should be paid to fluid oozing from the nipple. Clear or yellowish discharge, which is frequently associated with hormonal shifts, may be harmless. Any odd discharge, though, should be investigated further, particularly if it is bloody or persistent. Importantly, one or both breasts may experience nipple discharge. Healthcare professionals might use this distinction to assess its significance.

The skin may thicken or begin to dim. The skin may occasionally become reddish, which could be a sign of underlying problems. The skin around the breasts may also undergo alterations. Puckering or doping could be a sign of an underlying problem that needs further examination.

You can have early breast cancer detection if you listen to your body and notice any odd changes. Maintaining awareness of your state requires regular self-examination.

Screening for Breast Cancer

Screening is one of the most crucial phases in the early diagnosis and treatment of breast cancer. The goal of breast cancer screening is to find abnormalities before symptoms show up, thereby enhancing the effectiveness of treatment. Mammograms have historically been the most old and popular screening test.

Further tests, such as MRI scans or ultrasounds, which provide more precise views of the breast tissue, might be necessary if anomalies are discovered. A biopsy, in which a small sample of breast tissue is analyzed to ascertain whether the cells are malignant, is necessary for a conclusive diagnosis.

AI breast cancer detection solutions have been developed to improve detection rates and accuracy as a result of technological advancements. NIRAMAI (Non-Invasive Risk Assessment with Machine Intelligence) is one such cutting-edge AI-powered approach. NIRAMAI is a non-invasive, painless, radiation-free method of early-stage breast cancer detection that combines artificial intelligence with thermal imaging. For younger women and those with dense breast tissue, where standard mammography might not be so helpful, this approach is very helpful. NIRAMAI assists radiologists in making prompt decisions that enhance patient outcomes.

Treatments:

Treatments for breast cancer are determined by the cancer’s type and stage as well as the patient’s circumstances. Here is a summary of certain therapies:

Lumpectomy: Frequently performed for early-stage cancer, involves removing the tumor along with a tiny margin of surrounding tissue.

Mastectomy: When cancer is further advanced or as a preventive precaution, one or both breasts are removed, either completely or partially.

Sentinel Lymph Node Biopsy: It involves removing a small number of lymph nodes to look for the spread of cancer.

Dissection of Axillary Lymph Nodes: If cancer is discovered in the sentinel nodes, more lymph nodes are removed.

Radiation Therapy: Targets and eliminates breast cancer cells as well as those in the surrounding. It is frequently used to lower the chance of recurrence following surgery, particularly lumpectomies.

Chemotherapy: Uses medications to kill cancer cells; usually applied to larger tumors, more aggressive tumors, or cancers that have spread to other body parts.

Neoadjuvant Chemotherapy: Used to reduce tumor size before surgery.

Adjuvant Chemotherapy: Used to eradicate any cancer cells that may still be present after surgery.

Endocrine Therapy (Hormone Therapy): For breast tumors that have hormone receptors, it is used. It inhibits progesterone or estrogen, which can promote the growth of cancer.

Targeted Therapy: Focuses on particular chemicals that contribute to the development of cancer. Compared to chemotherapy, these treatments typically have fewer adverse effects.

CDK4/6 Inhibitors: Used to treat malignancies that express hormone receptors, these drugs target the division of cancer cells.

Immunotherapy: Aids the immune system in identifying and eliminating cancerous cells. As a treatment for breast cancer, especially triple-negative breast cancer.

Conclusion

Breast cancer is a complex disease that impacts many lives, but awareness, education, and early breast cancer detection can significantly improve outcomes. With advances in breast cancer screening technologies, including AI breast cancer detection, diagnosing the disease has become more efficient and accessible. Understanding the symptoms, types, and treatment options is crucial for anyone affected by breast cancer. By being proactive and attentive to changes in breast health, individuals can take critical steps toward early detection and effective treatment, ultimately leading to better prognoses and healthier futures.

Take control of your breast health right now with the advanced Thermalytix screening from NIRAMAI. Select from more than 150+ locations or arrange an appointment for screening at home. To schedule now and obtain your certified report, click this link!

Bengaluru, 28th September, 2022: Niramai, the innovative health-tech Indian company which has developed the world-renowned radiation-free, automated and non-invasive breast cancer screening test has launched a new initiative in the October Breast Cancer Awareness Month. Now, community healthcare providers, NGOs and public health workers who are conducting health awareness talks can also perform screening camps in conjunction. This new initiative offers “Easy Launch Kits” for breast cancer screening as a special ‘Starter Kit’ for socially concerned organizations enabling them to provide accurate breast cancer screening services by spending just Rs 1000 per day. This kit enables partner cancer societies, hospitals, diagnostic centers, and NGOs to provide Niramai’s automated ai breast cancer screening service for unlimited monthly screenings to triage population and identify patients with high suspicion of breast malignancy. This limited period offer with bookings available from 1st – 31st October on ‘First come first serve basis’, will help screenings become accessible and affordable to more women.

Dr. Geetha Manjunath’s Vision for Early Detection and Accessibility

Dr. Geetha Manjunath, CEO & Founder,
Niramai, said, “It is extremely crucial to encourage more and more women to get screened every year to enable early-stage detection and early treatment intervention which not only save lives but also reduces treatment costs. Early stage breast cancer detection makes the person go back to normal life very soon. Since our test provides a “changing room” experience where nobody sees or touches the women during the test, we have so far received excellent feedback from both urban and rural women. There are many socially concerned organizations who actually have similar mission of early breast cancer detection, but they were unable to provide free screening services due to the exorbitant costs of hiring a mobile mammography van. With the launch of our Starter Kit, we are enabling a collaborative platform to make screenings accessible and scalable to save thousands of women.  ”

Expanding Partnerships for Accessible Breast Cancer Screenings

Niramai has been at the forefront of bringing safe, economical, and accessible screening solutions to women across age groups and sections of the society. With this launch, Niramai hopes to impact the lives of more women positively by encouraging them to go for screenings at their nearest diagnostic center, hospital or NGO. Niramai has partnered with reputed healthcare providers such as Apollo Clinics, HCG hospitals, Medall Diagnostics, Rainbow Hospital and Medanta and more, to provide the novel ai breast cancer screening solution in their facility as well as conduct outreach programs in apartment complex. 

Niramai Global Reach 

Niramai has conducted over 70,000 screenings in India and is operational in over 150 installations at hospitals and diagnostic centres across 29 Indian cities. Niramai also launched Home Screenings service in collaboration with Healthians, Apollo, MiyaraWomen, ProactiveForHer and others.  Niramai has also started international commercial activity in Kenya, UAE, Turkey, UK, Switzerland, Sweden and USA. Niramai is the 1st Indian startup in the female healthcare space to have received regulatory approval from two major global regulatory bodies – the US FDA clearance and the European CE Mark Approval.

Free Breast Health Helpline

Niramai has also launched a free whatsapp chatbot for urban women on +91 94834 34444. This is a free “breast health help line” where women can ask any questions related to breast health and evaluate their risk to breast cancer using a validated Machine-Learning-based risk assessment service called with a easy and user-friendly interface through Niramai’s ChatBot. This online assessment test takes only a few minutes and the results are provided within minutes.